These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 33673143)
1. miR-34a and miR-200c Have an Additive Tumor-Suppressive Effect on Breast Cancer Cells and Patient Prognosis. Mansoori B; Silvestris N; Mohammadi A; Khaze V; Baghbani E; Mokhtarzadeh A; Shanehbandi D; Derakhshani A; Duijf PHG; Baradaran B Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33673143 [TBL] [Abstract][Full Text] [Related]
2. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4. Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion. Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483 [TBL] [Abstract][Full Text] [Related]
4. Bioluminescence Imaging for Monitoring miR-200c Expression in Breast Cancer Cells and its Effects on Epithelial-Mesenchymal Transition Progress in Living Animals. Liu J; Shen JX; He D; Zhang GJ Mol Imaging Biol; 2018 Oct; 20(5):761-770. PubMed ID: 29532351 [TBL] [Abstract][Full Text] [Related]
5. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52. Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-200c Inhibits the Metastasis of Triple-Negative Breast Cancer by Targeting ZEB2, an Epithelial-Mesenchymal Transition Regulator. Chen H; Li Z; Zhang L; Zhang L; Zhang Y; Wang Y; Xu M; Zhong Q Ann Clin Lab Sci; 2020 Jul; 50(4):519-527. PubMed ID: 32826250 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-200c and microRNA-31 regulate proliferation, colony formation, migration and invasion in serous ovarian cancer. Ibrahim FF; Jamal R; Syafruddin SE; Ab Mutalib NS; Saidin S; MdZin RR; Hossain Mollah MM; Mokhtar NM J Ovarian Res; 2015 Aug; 8():56. PubMed ID: 26260454 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1. Liu PL; Liu WL; Chang JM; Chen YH; Liu YP; Kuo HF; Hsieh CC; Ding YS; Chen WW; Chong IW PLoS One; 2017; 12(7):e0180844. PubMed ID: 28727734 [TBL] [Abstract][Full Text] [Related]
9. miR-200c dampens cancer cell migration via regulation of protein kinase A subunits. Sigloch FC; Burk UC; Biniossek ML; Brabletz T; Schilling O Oncotarget; 2015 Sep; 6(27):23874-89. PubMed ID: 26203557 [TBL] [Abstract][Full Text] [Related]
10. Dual Suppressive Effect of miR-34a on the FOXM1/eEF2-Kinase Axis Regulates Triple-Negative Breast Cancer Growth and Invasion. Bayraktar R; Ivan C; Bayraktar E; Kanlikilicer P; Kabil NN; Kahraman N; Mokhlis HA; Karakas D; Rodriguez-Aguayo C; Arslan A; Sheng J; Wong S; Lopez-Berestein G; Calin GA; Ozpolat B Clin Cancer Res; 2018 Sep; 24(17):4225-4241. PubMed ID: 29748184 [No Abstract] [Full Text] [Related]
11. Knockdown of circDENND4C inhibits glycolysis, migration and invasion by up-regulating miR-200b/c in breast cancer under hypoxia. Ren S; Liu J; Feng Y; Li Z; He L; Li L; Cao X; Wang Z; Zhang Y J Exp Clin Cancer Res; 2019 Sep; 38(1):388. PubMed ID: 31488193 [TBL] [Abstract][Full Text] [Related]
12. LncRNA SNHG7 contributes to tumorigenesis and progression in breast cancer by interacting with miR-34a through EMT initiation and the Notch-1 pathway. Sun X; Huang T; Liu Z; Sun M; Luo S Eur J Pharmacol; 2019 Aug; 856():172407. PubMed ID: 31132353 [TBL] [Abstract][Full Text] [Related]
13. SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1/2. Zhang N; Zhang H; Liu Y; Su P; Zhang J; Wang X; Sun M; Chen B; Zhao W; Wang L; Wang H; Moran MS; Haffty BG; Yang Q Cell Death Differ; 2019 May; 26(5):843-859. PubMed ID: 29988076 [TBL] [Abstract][Full Text] [Related]
14. Effects of miR-200c on the migration and invasion abilities of human prostate cancer Du145 cells and the corresponding mechanism. Shi R; Xiao H; Yang T; Chang L; Tian Y; Wu B; Xu H Front Med; 2014 Dec; 8(4):456-63. PubMed ID: 25363395 [TBL] [Abstract][Full Text] [Related]
15. Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Howe EN; Cochrane DR; Richer JK Breast Cancer Res; 2011 Apr; 13(2):R45. PubMed ID: 21501518 [TBL] [Abstract][Full Text] [Related]
16. miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer. Zhao XG; Hu JY; Tang J; Yi W; Zhang MY; Deng R; Mai SJ; Weng NQ; Wang RQ; Liu J; Zhang HZ; He JH; Wang HY Cell Death Dis; 2019 Jun; 10(7):479. PubMed ID: 31209222 [TBL] [Abstract][Full Text] [Related]
17. miR-200c inhibits metastasis of breast cancer cells by targeting HMGB1. Chang BP; Wang DS; Xing JW; Yang SH; Chu Q; Yu SY J Huazhong Univ Sci Technolog Med Sci; 2014 Apr; 34(2):201-206. PubMed ID: 24710933 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of suppressive microRNAs, miR-30a and miR-200c are associated with improved survival of breast cancer patients. Kawaguchi T; Yan L; Qi Q; Peng X; Gabriel EM; Young J; Liu S; Takabe K Sci Rep; 2017 Nov; 7(1):15945. PubMed ID: 29162923 [TBL] [Abstract][Full Text] [Related]
19. miR-200 promotes the mesenchymal to epithelial transition by suppressing multiple members of the Zeb2 and Snail1 transcriptional repressor complexes. Perdigão-Henriques R; Petrocca F; Altschuler G; Thomas MP; Le MT; Tan SM; Hide W; Lieberman J Oncogene; 2016 Jan; 35(2):158-72. PubMed ID: 25798844 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]